In-vivo sentinel lymph node mapping in patients with colorectal cancer
- Conditions
- Colorectal carcinoma10017990
- Registration Number
- NL-OMON30234
- Lead Sponsor
- Jeroen Bosch Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Colorectal carcinoma
Age > 18 years
No metastases
Fit for treatment
Exclusion Criteria
Age < 18 years
Previous resection on the colon/ rectum
Pregnant women
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>1. To define whether SLNM can adequately identified nodal involvement in<br /><br>CRC<br /><br>2. To define detection rate (upstaging) and aberrant nodal drainage.</p><br>
- Secondary Outcome Measures
Name Time Method <p>1. To determine which factors may influence the concept of SLN, such as<br /><br>tumorsize, location etc.</p><br>